Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease).
Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC.
Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC. J Thorac Oncol. 2024 Jun; 19(6):877-882.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Humans
Immunotherapy
Kelch-Like ECH-Associated Protein 1
Lung Neoplasms
Mutation
Precision Medicine
authors with profiles
Marina Chiara Garassino